Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$17,240,482
-$4,817,607 QoQ
Shares Held
136,461
-13.8% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#346
of 2,265 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOKF, NA holds $220,983,153 across 10 Drug Manufacturers - General names. GILD ranks #5 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
51,087 | $61,275,284 | |
| 2 | ABBV |
AbbVie Inc.
|
194,942 | $49,055,203 | |
| 3 | JNJ |
Johnson & Johnson
|
142,681 | $36,236,693 | |
| 4 | AMGN |
Amgen Inc
|
67,477 | $24,434,770 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
136,461 | $17,240,482 | |
| 6 | MRK |
Merck & Co., Inc.
|
114,907 | $14,765,549 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
244,226 | $14,072,301 | |
| 8 | PFE |
Pfizer Inc
|
82,045 | $1,975,643 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,240,482 | 136,461 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $22,058,089 | 158,270 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $14,207,645 | 115,754 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $12,626,916 | 113,756 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $11,511,631 | 103,830 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $11,732,418 | 104,707 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $10,025,931 | 108,541 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,935,247 | 106,575 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,720,957 | 112,534 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $9,114,716 | 124,433 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,328,868 | 115,157 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,730,359 | 116,498 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,629,450 | 111,969 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $9,606,432 | 115,782 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $10,503,660 | 122,349 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $7,669,979 | 124,331 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $8,240,076 | 133,313 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $7,872,190 | 132,417 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $8,915,563 | 122,787 | Shares | Other | 2022-03-11 | |
| 2021-09-30 | $5,039,328 | 72,145 | Shares | Other | 2021-11-10 | |
| 2021-03-31 | $3,918,387 | 60,628 | Shares | Other | 2021-04-21 | |
| 2020-12-31 | $5,921,312 | 101,636 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $8,797,374 | 139,221 | Shares | Other | 2020-10-30 | |
| 2020-06-30 | $12,347,792 | 160,486 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $9,351,876 | 125,092 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||